Vergent Bioscience Raises $8.7 Million in Series A Financing Led by Spring Mountain Capital

MINNEAPOLIS, June 12, 2018 -- (Healthcare Sales & Marketing Network) -- Vergent Bioscience, a cancer-focused biotechnology company, announced today that it raised $8.7 million in a Series A financing round led by Spring Mountain Capital to fund its precli... Diagnostics, Oncology, Venture Capital Spring Mountain Capital, Vergent Bioscience, fluorescent probe
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news